Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bonini

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2013
Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancerR Orlandi, M De Bortoli, C M Ciniselli, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Leukemia|May 2, 2008
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donorsB Mazzi, T D Clerici, M Zanussi, et al.
Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|June 16, 2015
Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overallM Noviello, A Forcina, V Veronica, et al.
Leukemia|November 6, 2014
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationL Crucitti, R Crocchiolo, C Toffalori, et al.
Heart, Lung and Vessels|July 16, 2014
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemiaR Greco, N Mancini, J Peccatori, et al.
Leukemia|June 5, 2014
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donorsJ Peccatori, A Forcina, D Clerici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2021
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)P J Hayden, C Roddie, P Bader, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2013
Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancerR Orlandi, M De Bortoli, C M Ciniselli, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Leukemia|May 2, 2008
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donorsB Mazzi, T D Clerici, M Zanussi, et al.
Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|June 16, 2015
Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overallM Noviello, A Forcina, V Veronica, et al.
Leukemia|November 6, 2014
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationL Crucitti, R Crocchiolo, C Toffalori, et al.
Heart, Lung and Vessels|July 16, 2014
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemiaR Greco, N Mancini, J Peccatori, et al.
Leukemia|June 5, 2014
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donorsJ Peccatori, A Forcina, D Clerici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2021
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)P J Hayden, C Roddie, P Bader, et al.
Pageof 8